Overview

Efficacy and Safety of Slow Release DHEA

Status:
NOT_YET_RECRUITING

Trial end date:
2028-09-30

Target enrollment:

Participant gender:

Summary

There is evidence to suggest that DHEA-based treatment could be beneficial to patients with asthma, yet one of the main treatments for asthma (taking glucocorticoids, a hormone that is effective in reducing inflammation), suppresses the production of DHEA. In this study, the investigators want to test and evaluate the safety of DHEA-based treatment.

Phase:

PHASE2

Details

Lead Sponsor:

Indiana University

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Dehydroepiandrosterone